Diabetes Mellitus Flashcards

1
Q

Define diabetes

A

Group of metabolic diseases characterized by chronic hyperglycemia due to disorders of Carbohydrate, protein & fat metabolism & resulting from defects in Insulin secretion, Insulin action or both.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the acute complications is DM associated with?

A

Associated with acute complications
1. Hyperglycemic Hyperosmolar State (HHS),
2. Diabetic Ketoacidosis (DKA), Lactic Acidosis
3. Hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the long complications is DM associated with?

A

Retinopathy, Nephropathy, Neuropathy and Vasculopathy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epidemiology of diabetes

A

Globally, the number of people with DM has quadrupled in the past three decades and Diabetes mellitus is the 9th major cause of death. (WHO, 2019)

Diabetes presently causes 3.7-5 million deaths per year, mostly from cardiovascular diseases & it is expected to become the 7th leading cause of death globally by 2030.

About 1 in 10 adults worldwide now have diabetes mellitus, 95% of whom have T2DM ( 9.3% prevalence worldwide)

Although genetic predisposition partly determines individual susceptibility to DM, an unhealthy diet and a sedentary lifestyle are important drivers of the current global epidemic

537 million adults (20-79 years) are living with diabetes - 1 in 10. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. Over 3 in 4 adults with diabetes live in low- and middle-income countries

Diabetes facts and figures show the growing global burden for individuals, families, and countries. The IDF Diabetes Atlas (2021) reports that 10.5% of the adult population (20-79 years) has diabetes, with almost half unaware that they are living with the condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the ADA & WHO, consensus classification?

A

TIDM- absolute Insulin deficiency, may be idiopathic or immune mediated,

T2DM-may range from predominantly insulin resistance with relative insulin deficiency to a predominantly insulin secretory defect with insulin resistance.

Other Specific Types of DM

GDM- DM during pregnancy, remits after delivery with return to frank T2DM in 50% of pts with GDM later in life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the Etiologic Classification of DM?

A
  1. Type 1 DM:
    - Immune mediated
    - Idiopathic
  2. Type 2 DM
  3. Other Specific Types
    - Genetic defects of β-cell function
    - Genetic defects in insulin action
    - Diseases of the exocrine pancreas
    - Endocrinopathies
    - Drug or chemical induced
    - Infections
    - Uncommon forms of IMD (insulin-mediated diabetes)
    - Other genetic syndromes sometimes associated with diabetes
  4. GDM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of Genetic Defects DM

A

a) of beta cell function;
MODY 1-14
Types 1,3,5-hepatic transcription
Types 2,4 - mutation of Glucokinase and Islet cells
b) in Insulin action;
Type A insulin resistance, Leprechaunism, Rabson-Mendenhall syndrome, Lipodystophy Syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Discuss disease of the Exocrine pancreas as a type of DM

A

Acute/Chronic Pancreatitis, Cystic fibrosis, Carcinoma, Hemochromatosis, Pancreatectomy, Fibrocalculous pancreatopathy.

How: CF causes thick mucus buildup in the pancreas, leading to fibrosis of pancreatic tissue and damage to insulin-producing beta cells in the islets of Langerhans.

Hemochromatosis causes diabetes, often referred to as “Bronze Diabetes,” due to excessive iron deposition in the pancreas, leading to insulin deficiency and insulin resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discuss diabetes caused by Endocrinopathies

A

increased insulin resistance; eg Cushings Syndrome, acromegaly, glucagonoma, Hyperthyroidism:
- decreased insulin secretion; eg somatostatinoma,
- affects both a/b; eg pheocromocytoma
OTHERS – Aldosteronoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discuss diabetes caused by drugs

A

a) increased insulin resistance-Glucocorticoids; Thyroid hormones
b) decreased insulin secretion-Thiazides, beta-adrenergic agonists

OTHERS DRUGS- Nicotinic acid, Protease Inhibitors, pentamidine, diazoxide, phenytoin, α-interferon, clozapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CHEMICAL INDUCED DM

A

Vacor

Vacor is a rodenticide that can cause permanent diabetes mellitus by selectively destroying pancreatic beta cells, leading to insulin deficiency, similar to Type 1 Diabetes Mellitus (T1DM).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the Infections that cause DM (the 3 C’s) ?

A
  1. Congenital rubella
  2. Cytomegalovirus
  3. Coxsackie

Congenital rubella, cytomegalovirus (CMV), and coxsackievirus can all cause diabetes mellitus (virus-induced diabetes) by targeting pancreatic beta cells, leading to insulin deficiency. This is particularly linked to Type 1 Diabetes Mellitus (1DM), as these viruses can trigger autoimmune destruction of beta cells or directly damage them.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are Uncommon forms of Immune-mediated DM?

A

a) “Stiff-person” Syndrome;
an autoimmune disorder of CNS;
Clinical feature: stiffness and painful muscle spasms,
High titres of GAD in Pancreas and CNS,
1/3 of patients develop β-cell dysfunction and DM

Why high titres of GAD?

  • GAD (Glutamic Acid Decarboxylase) is an enzyme involved in GABA (gamma-aminobutyric acid) synthesis, a key inhibitory neurotransmitter in the CNS.
  • It is found in both the brain and pancreas (in beta cells)
  • In SPS autoantibodies attack GAD, which affects GABA production, causing muscle stiffness and spasms
  • Because GAD is ALSO in the pancreas, the immune system also attacks beta cells causing insulin deficiency.

• High titers of GAD antibodies are found in both the pancreas and CNS, suggesting an autoimmune attack on these tissues.

b) Anti-insulin receptor Antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are Genetic syndromes associated with dm?

A
  • Downs Syndrome
  • Prader-Willi syndrome
  • Klinefelter’s Syndrome
  • Porphyria
  • Turners Syndrome
  • Friedreich’s ataxia
  • Wolfram’s Syndrome
  • DI+DM+Optic Atrophy+Deafness = DIDMOAD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is diabetes diagnosed?

A
  • Symptoms of diabetes plus random blood glucose concentration ≥ 11.1mmol/L or
  • Fasting Plasma Glucose ≥ 7.0mmol/L or
  • Hemoglobin A1c (HbA1c) ≥ 6.5% or
  • 2-h plasma glucose ≥ 11.1mmol/L during an oral glucose tolerance test (OGTT)

Why HbA1c?

When blood sugar (glucose) is high, glucose attaches to hemoglobin, forming glycated hemoglobin (HbA1c).

• The higher the blood sugar levels, the more HbA1c is formed.

• Since red blood cells live for about 3 months, HbAlc shows average blood sugar levels over that time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can we determine pre-diabetes?

A

IFG (impaired fasting glucose) FPG 6.1 to 6.9 mmol/L

IGT (impaired glucose tolerance) - Random blood glucose & 2hr post prandial between 7.8 and 11.0mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the new values for diagnosis of Hyperglycemia?

A

Diabetes
fasting 7.0mmol/L & above
RBG & 2hr post prandial ≥ 11.1mmol/L
If above occurs on 2 seperate occasions and patient is asymptomatic = DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Type 1 DM?
What are the symptoms?

A

Type 1 diabetes (previously known as insulin-dependent, juvenile or childhood-onset) is characterized by deficient insulin production and requires daily administration of insulin.

In 2017 there were 9 million people with type 1 diabetes; the majority of them live in high-income countries.Neither its cause nor the means to prevent it are known

Symptoms include:
* excessive excretion of urine (polyuria), thirst (polydipsia)
* constant hunger (polyphagia)
* weight loss
* vision changes
* and fatigue.

These symptoms may occur suddenly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does T1DM present (characteristics)?

A

Characteristics;
- Young age, usually <30yrs & thin,
- rapid onset with severe symptoms
- Blood glucose high with ketonuria (due to the body using fat instead of glucose for energy resulting in production of ketones) ,
- mainly auto-immune etiology
presence of antibodies to Islet cells
association with HLA-haplotypes DR3/4, DQb-chain,
- concordance is ~50% in identical twins.
- Requires Insulin for survival.
- Rarely presents with poor wound healing / Long-term DM specific complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do T2DM present?

A

T2DM
- Most common,~90% of DM,
- Strong genetic basis (polygenic); no association with HLA (because it’s not an autoimmune disease like T1DM)
- beta-cell dysfunction (?genetic), with reduced secretion and increased resistance
- Presents classical symptoms, of gradual onset,
- Age of onset ~30yrs, obese, +ve family hx
- Relative Insulin deficiency, Strong genetic basis is polygenic
- Diagnosed 5-7yrs after onset of impaired glycaemia.
- Uncommonly present with Ketosis as preserved insulin suppresses ketogenesis.
- Doesn’t require Insulin for survival.
- From the TRIUMVIRATE to the OMINOUS OCTET

12
Q

What are the RISK FACTORS FOR TYPE 2 DM?

A
  • Family History of Diabetes (1st degree relative)
  • Obesity/Overweight (BMI>25mg/m2)
  • Habitual Physical Inactivity
  • Race/ethnicity (e.g. African American, Latino, * Native American, Asian American, Pacific Islander)
  • Previously identified IFG or IGT
  • History of GDM / Delivery of Macrosomic baby (≥4kg) / Peri uterine deaths
  • Hypertension (BP ≥ 140/90mmHg)
  • Dyslipidemia (HDL < 35 mg/dl (0.90mmol/L) and/or Tg level >250mg/dl)(2.82mmol/L)
  • Polycystic Ovarian Syndrome (PCOS)
  • Acanthosis Nigricans
  • History of vascular disease
13
Q

Key Contributors to T2DM (IDF)

A

Urbanization
An ageing population
Decreasing levels of physical activity
Increasing overweight and obesity prevalence

14
Q

How does GDM present?

A
  • Dm discovered during pregnancy, btwn 24-28wks of gestation.
  • Hx of GDM in previous pregnancies.
  • Affects 3-5% of pregnant women.
  • 50% dev T2DM in ~10yrs later in life,
  • 95%revert to normoglycaemia 6/52wks after delivery.
  • Like inT2DM, Insulin Resistance state heightened by placental hormones.
14
Q

What is the daily secretion of insulin? What is its function? How is it secreted and how does it become insulin?

A

Insulin- daily secretion is 30units.

major culprit in utilization of the metabolic fuels by the liver,adipose tissue and skeletal muscles.
Has anabolic (mainly) and catabolic effects.

Secreted as pre-proInsulin ->Proinsulin. Proinsulin -> Insulin +C-peptide, this conversion is energy free and occurs within 2-4 hrs.

14
What are the Factors that affect insulin secretion?
- Oral glucose stimulates more insulin secretion than IV glucose (due to incretins, gut hormones that are released when glucose is infested orally, enhancing insulin release) - Proteins stimulate glucose release to a greater extent than fatty acids and triglycerides - Ca and Phosphates,
15
What is indicative of Insulin Resistance?
- pro Insulin/insulin ratio is indicative of Insulin Resistance. - Ratio of >25-40% is indicative of beta-cell dysfunction and may herald T2DM.
16
Describe insulin action
Insulin action - is initiated by binding to insulin receptors (on target cells eg. Muscle, fat and liver), - it facilitates glucose transport into muscles and fat cells with glucose transporters across cell membranes. Action is terminated by degradation mainly in the 1) Liver ; 1st pass eliminates ~40--60% 2) Binding to peripheral receptors, internalized and degraded by proteases and glutathiones. 3) Renal for 10-20% Insulin degradation and filtration by the tubules. Hence, Insulin requirements fall in patients with ESRD.
17
Discuss the function of C peptide Where is it excreted?
-co-secreted with Insulin in equimolar amounts, -excreted by the kidneys -used in determining endogenous Insulin secretion
18
What are the insulin antagonists?
Glucagon: a polypeptide, secreted by the alpha-cells of the pancreas, level increases 2-4ce (2-4 times) in hypoglycemia and decreases by ~50% in hyperglycemia, Increase level +increase insulin level has no change in glucose production i.e. BIHORMONAL RESPONSE. Glucocorticoids,
19
Insulin resistance is associated with which CVD risk factors? And which metabolic syndromes?
Affects ~30% of adults (USA), Associated with CVD risk factors: obesity (visceral), HBP, Dyslipidemia, increase uric acid. Others –fibrinogen, CRP (C reactive protein) ,increase Plasminogen activator Inhibitor, sedentary life-styles, microalbuminuria, endothelial dysfunction. Metabolic Syndrome: Studies suggest overlap in 3 domains of 1 Hypertension- HBP+ BMI>25 2 IGT (impaired glucose tolerance) domain - increase FPG+ increase fasting Insulin 3 Central MS - Insulin resistance, BMI>25, central obesity, - Increase Triglyceride + low HDL-cholesterol .
20
Metabolic Syndrome: Studies suggest overlapp in 3 domains of 1 Hypertension- HBP+ BMI>25 2 IGT domain - incr FPG+ incr fasting Insulin 3 Central MS - Insulin resistance, BMI>25, central obesity, - Incr Trigly + low HDL-chol.
21
SCREENING FOR DM
T1DM- not recommended. T2DM- risk factors include age >30yrs, family hx of DM, hx of GDM, HBP,Obesity, Ethnicity and race, sedentary life style. SCREENING METHODS; FBS repeatedly, OGTT, HbA1c – problems of methodology/standardization sorted HbA1c 5.7-6.4% = Pre- diabetes (ADA) '' 6.1-6.4 = Pre-diabetes (IDF)
22
HbA1c
HbA1c assay methods; ion-exchange HPLC. boronate affinity chromatography. immunologic methods. Values are influenced by Hb variants; S,C,D,Grazz, HbA1c >6.5% is diagnostic for DM 5.7-6.4% = Pre-Diabetes > 8% signifies poor DM control Target for optimal glycemic control <7%
23
Usefulness of HbA1c
strongly predictive of DM complications indicator for glycemic control goals asseses BG control on short term basis evaluates of need for Rx changes
24
ACUTE COMPLICATIONS of DM
DKA; associated with kussmaul’s breathing HHS, HYPOGLYCEMIA LACTIC ACIDOSIS
25
Classification of complications
Acute vs Chronic Chronic Vascular Avascular Vascular Microvascular Macrovascular
26
MICROVASCULAR complications
MICROVASCULAR. 1. DM Retinopathy: background and or proliferative. 2. DM Neuropathy: * clinical DM neuropathy; * distal symmetrical sensory motor * focal/multifocal eg Cr N, Entrapment syndrome * autonomic-diabetic diarrhea/incontinence,gastroparesis * genito-urinary eg ED, urinary incontinence * cardiovascular: CAN 3. DM Nephropathy
27
Microvascular complications
1. DM Retinopathy: * Background (non-proliferative): Microaneurysms, dot/blot hemorrhages, cotton wool spots. * Proliferative: Neovascularization, vitreous hemorrhage, risk of blindness. 2. DM Neuropathy:clinical DM neuropathy; * distal symmetrical sensory motor (most common, “glove and stocking” distribution). * focal/multifocal eg Cr N, Entrapment syndrome: Cranial nerve palsies (e.g., CN III, VI), entrapment syndromes (e.g., carpal tunnel). * autonomic-diabetic diarrhea/incontinence,gastroparesis * genito-urinary eg ED, urinary incontinence * cardiovascular: CAN (Cardiovascular autonomic neuropathy: Postural hypotension, arrhythmias) 3. DM Nephropathy * glomerulosclerosis * pylonephritis
28
What are the MACROVASCULAR COMPLICATIONS?
Coronary Artery disease Peripheral Artery disease Cerebrovascular disease
29
What are the avascular complications?
* Predeliction for certain infections eg fungal, pseudomonas, malignant otitis externa, bacterial chest & UTIs * Dermatology- Necrobiosis lipodica diabeticorum, * Connective tissue dx eg Dupuytrens contracture, Frozen shoulder syndrome, Trigger finger, Gout, Juvenile cheiroarthropathy * Cataracts * Glaucoma * Periodontal disease
30
Other complications
* Autonomic Dysfunction * Diabetic Foot Ulcer/Syndrome (both micro & macrovascular
31
Risks of complications
RISKS- DM specific complications are related to glycemia over time and affected by tissue permability to glucose. It is lowered by lowering blood glucose risk for dev retinopathy and neuropathy persists over duratn of DM risk for Nephropathy peaks @ 15-20 yrs and later falls. Non Specific complicatns of DM due to Artherosclerosis, related to attained age, commoner in females reflects underlying risk for race and ethnic groups.
32
Management
AIM- a) Aleviate symptoms, b) achieve near normal glycaemia + HbA1c< 6.5%-7.0% c) improve QOL. STEPS- Life style intervention Excercises- non-impact (aerobic) better than resistance Aim for HbA1C OF<6.5 -7% Loss of near normal glycemia is indication for combination therapy. Modern concept - Intensive Rx to target ; Results in - decrease in and dev/progress of DM-specific complications, - removes added risks to fetus and infants of DM mothers NB. Despite advances in modern Rx, little reduction in Macrovascular complications is noted.
33
Targets in management
(1) GOALS for Intensive Rx: FBG: 4 - 6 mmol/L Peak 2HPP: < 10mmol/L HbA1C <6.5% (2) GOALS for Conventional Rx: FBG: 4 - 7 mmol/L Peak 2HPP: < 11.1mmol/L HbA1C <7.0% GOALS for Conventional Rx is to avoid symptoms of hypo or hyperglycaemia.
34
Monitoring of Blood Glucose
HbA1C <7.0% = Good glycemic control HbA1C > 7.0% = Poor or suboptimal glycemic control HbA1C should be done once in 3 months (3-4 times per year) If well controlled, once or twice per year will suffice
35
COMPLICATIONS OF INSULIN Rx
-Hypoglycaemia, hypoglycaemia Unawareness when pts have no protective symptoms of severe clinical hypoglycemia cause upregulation of glucose transport in the CNS protecting the brain from hypoglycemia -Insulin Lipodystrophy or Lipoatrophy -Insulin Allergy, now rare. (Local or Systemic) - Bilateral pedal swelling
36
DRUG TREATMENT ORAL HYPOGLYCEMICS
a) Sulfonyureas;improves insulin secretion -binds to b-cell receptor chlorpropamide 1st geneneration glimepiride/glibenclamide 2nd generation Meglitinide; incr insulin secretion in presence of glucose repaglitinide – short half life, taken just b4 meals Alpha glucosidase inhibitors; acarbose, miglitol Biguanides ; metformin PPARs ; thiazolidinediones rosiglitazone, poiglitazone they also modify lipid parameters of trigly and HDL- cholesterol INCRETIN mimetics; DPP4I & GLP- 1 agonists: stimulates insulin secretion, antagonisis glucagon secretion,eg eg: exanetide,sitagliptin, liraglutide
37
List of Drugs used in T2DM
Biguanides Sulfonylureas Meglitinide derivatives Alpha-glucosidase inhibitors Thiazolidinediones (TZDs) Glucagonlike peptide-1 (GLP-1) agonists Dipeptidyl peptidase IV (DPP-4) Inhibitors Selective sodium-glucose transporter-2 (SGLT-2) inhibitors Insulins Amylinomimetics Bile acid sequestrants Dopamine agonists